C Lemaitre,P-A Thiebaut,A François et al.
C Lemaitre et al.
Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review [0.03%]
具有独特的影像特征的黏液性肝细胞腺瘤（HCA）罕见亚型一例并文献复习及免疫组化和分子分析
Nicolas De Vos,Joni Van der Meulen,Malaïka Van Der Linden et al.
Nicolas De Vos et al.
Preoperative imaging and histopathology, immunohistochemistry and molecular analysis after resection of 2 hepatocellular adenomas (HCAs) (20 and 2cm) in a 53-year-old female patient were performed. On imaging, the large lesion resembled a m...
Vincent Zimmer,Frank Lammert
Vincent Zimmer
The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients [0.03%]
血小板计数动力学可作为乙肝相关急性-on-慢性肝功能衰竭患者90天生存率的新型预测指标
Xuwen Xu,Zhouhua Hou,Yuyuan Xu et al.
Xuwen Xu et al.
Background: The prognosis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is extremely poor due to multiple organ dysfunction. Obje...
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort [0.03%]
直接抗病毒药物对丙型肝炎病毒患者肝癌复发生长的影响：AFEF/ANRS CO22 Hepather队列研究结果
Anais Vallet-Pichard,Jean-Michel Correas,Celine Dorival et al.
Anais Vallet-Pichard et al.
Background: Although it has now been excluded that direct-acting antivirals (DAA) are associated with a significant risk of hepatocellular carcinoma (HCC) in HCV-infected patients, a possible effect of DAA on tumor growth...
Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients [0.03%]
载药微球(TACE)与传统TACE治疗肝癌疗效及生存预测因素的全面分析研究
Changyong Chen,Huaiming Qiu,Yuanhui Yao et al.
Changyong Chen et al.
Background: Transarterial chemoembolization (TACE) is widely applied in hepatocellular carcinoma (HCC) patients who are not suitable for surgical treatment. We aimed to investigate the treatment outcomes and comprehensive...
The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients [0.03%]
KRAS突变类型决定了PI3Kα/γ信号依赖性：对胰腺导管腺癌患者靶向治疗选择的启示
Coralie Cayron,Julie Guillermet-Guibert
Coralie Cayron
Pancreatic ductal adenocarcinoma PDAC is a complex disease with an important diversity of genetic alterations found between patients. KRAS mutation is considered as a major oncogenic driver in this cancer (around 90% of the patients), but t...
Emilie Bouquet,Stéphanie Pain,Bernard Fauconneau et al.
Emilie Bouquet et al.
Outcome and risk of de novo Hepatitis B after liver transplantation: Are all anti-HBc-positive grafts the same? [0.03%]
肝移植后新发乙型肝炎的预后及风险：所有的抗HBc阳性的移植物都一样吗？
Mar Riveiro-Barciela
Mar Riveiro-Barciela
Angélique Vienot,Cindy Neuzillet
Angélique Vienot
Biliary tract cancers (BTC) are a heterogeneous group of epithelial neoplasms, with a poor prognosis. Advanced BTC remains a challenging, non-curable disease. In this review, we provide an overview of the medical treatment options in advanc...